EuroPCR Presentation of "Real World" ADVANCE Study Confirms Economic Value of Novel Self-Expanding Valve in Patients Unable to Undergo Surgery PARIS -- Focused on offering devices that provide both ...

Minneapolis-based Medtronic will appeal the Federal District Court of Delaware’s preliminary injuction granted to Irvine, Calif.-based Edwards Lifesciences. The Court issued the preliminary injunction ...

PARIS – New clinical data presented today at the European Society of Cardiology Congress 2011 demonstrate positive long-term performance for the CoreValve® transcatheter aortic valve replacement ...

Edwards Lifesciences Inc. says it will appeal a Delaware judge’s decision not to bar the manufacture and sale of Medtronic Inc.’s CoreValve aortic valve replacement. Medtronic Inc. (NYSE:MDT) managed ...

Patients implanted with the CoreValve transcatheter aortic valve replacement showed strong blood flow and improved quality of life at five years post-implant, according to results from two Medtronic ...

MINNEAPOLIS--(BUSINESS WIRE)--Medtronic, Inc. (NYSE: MDT) today announced it has completed patient enrollment in the extreme risk study in its CoreValve U.S. Pivotal Trial. The company also received ...

Wall Street and others are continuing to weigh in on Medtronic Inc.’s pending $700 million buy of Irvine device maker CoreValve Inc. Medtronic, which employs some 550 people at its Santa Ana heart ...

The U.S. Food and Drug Administration has approved Minneapolis-based Medtronic’s CoreValve Transcatheter for use without undergoing an independent device advisory panel review for the product, ...

An appeals court on Monday postponed an injunction that would limit U.S. sales of Medtronic Inc.’s CoreValve device. An appeals court on Monday postponed an injunction that would have limited U.S.

The new chief executive of Medtronic Inc., the Minneapolis medical device maker with 700 Orange County workers, has a challenge on his hands. Omar Ishrak, a former executive at GE Healthcare Inc., was ...

(Reuters) - A unit of medical device maker Medtronic plc must pay $106.5 million to competitor Colibri Heart Valve LLC for patent infringement, a Santa Ana, California federal jury said Wednesday. The ...

A federal jury in California said Wednesday that a unit of Medtronic must pay $106.5 million to competitor Colibri Heart Valve LLC for patent infringement. After a seven-day trial in Santa Ana, Calif.